FDA’S WARNING AGAINST  “3 HARD KNIGHTS”
Upcoming SlideShare
Loading in...5
×
 

FDA’S WARNING AGAINST “3 HARD KNIGHTS”

on

  • 313 views

On 2nd June 2014, The Food and Drug Administration (FDA) is advising consumers not to purchase or use “3 Hard Knights”. ...

On 2nd June 2014, The Food and Drug Administration (FDA) is advising consumers not to purchase or use “3 Hard Knights”.

3 Hard Knights is promoted and sold for sexual enhancement on various websites and in some retail stores.
FDA laboratory analysis confirmed that 3 Hard Knights contains sildenafil and thiosildenafil.

Statistics

Views

Total Views
313
Views on SlideShare
313
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

FDA’S WARNING AGAINST  “3 HARD KNIGHTS” FDA’S WARNING AGAINST “3 HARD KNIGHTS” Presentation Transcript

  • FDA’S WARNING AGAINST “3HARDKNIGHTS” Dr. P.Naina Mohamed Pharmacologist [0
  • INTRODUCTION  On 2nd June 2014, The Food and Drug Administration (FDA) is advising consumers not to purchase or use “3 Hard Knights”.  3 Hard Knights is promoted and sold for sexual enhancement on various websites and in some retail stores.  FDA laboratory analysis confirmed that 3 Hard Knights contains sildenafil and thiosildenafil.  Sildenafil is a Phosphodiesterase 5 (PDE 5) inhibitor and is approved for the treatment of Erectile Dysfunction (ED).  Thiosildenafil is a substance structurally similar to sildenafil.
  • POSSIBLE MECHANISM OF ACTION 3 Hard Knights Undeclared sildenafil and thiosildenafil Inhibition of Phosphodiesterase 5 (PDE 5) Inhibition of Breakdown of cGMP Increase the concentration of cGMP in smooth muscle of corpus cavernosum and penile arteries Smooth muscle relaxation Increase the blood flow to corpus cavernosum Penile Erection
  • INTERACTION WITH NITRATES 3 Hard Knights Undeclared sildenafil and thiosildenafil Interact with prescription drugs like nitrates (Nitroglycerin) Excessive dilation of smooth muscle of blood vessels Potentiation of Hypotensive effects Blood pressure reduced to dangerous levels Contraindicated
  • INTERACTION WITH PROTEASE INHIBITORS (ANTIRETROVIRALS) 3 Hard Knights Undeclared sildenafil and thiosildenafil Interact with Protease Inhibitors like Saquinavir, Ritonavir, Indinavir, Nelfinavir, Amprenavir, Fosamprenavir, Lopinavir, Atazanavir, , Tipranavir and Darunavir Protease Inhibitors block CYP3A4-mediated sildenafil metabolism Increased plasma levels of sildenafil Increased risk of sildenafil adverse effects (hypotension, visual changes, priapism) Contraindicated
  • INTERACTION WITH CYP3A4 INHBITORS 3 Hard Knights Undeclared sildenafil and thiosildenafil Interact with CYP3A4 Inhibitors like Macrolide antibiotics (Telithromycin, Erythromycin, Clarithromycin) and Antifungals (Voriconazole, Itraconazole, Ketoconazole) CYP3A4 Inhibitors block CYP3A4-mediated sildenafil metabolism Increased plasma levels of sildenafil Increased risk of sildenafil adverse effects (hypotension, visual changes, priapism)
  • CONCLUSION FDA warns the Consumers should stop using this product immediately and throw it away. FDA advises the Consumers who have experienced any negative side effects should consult a health care professional as soon as possible. FDA announces to the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building, and are often represented as being “all natural.” FDA claims that they are unable to test and identify all products marketed as dietary supplements on the market that have potentially harmful hidden ingredients. FDA advises the Consumers to exercise caution before purchasing any product in the above categories.
  • REFERENCES  http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingU singMedicineSafely/MedicationHealthFraud/ucm399606.htm?sour ce=govdelivery&utm_medium=email&utm_source=govdelivery  Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12e Laurence L. Brunton, Bruce A. Chabner, Björn C. Knollmann  Harrison's Online Featuring the complete contents of Harrison's Principles of Internal Medicine, 18e Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.  Hurst's The Heart, 13e Valentin Fuster, Richard A. Walsh, Robert A. Harrington  Basic & Clinical Pharmacology, 12e Bertram G. Katzung, Susan B. Masters, Anthony J. Trevor  Clinician's Pocket Reference, 11e Leonard G. Gomella, Steven A. Haist
  • REFERENCES  http://www.micromedexsolutions. com  http://www.nlm.nih.gov/medlinepl us/druginfo/meds/a699015.html  http://www.rxlist.com/viagra- drug/clinical-pharmacology.htm  http://www.medicinenet.com/silde nafil/article.htm  http://www.pfizer.com/files/produc ts/uspi_viagra.pdf